PMA device
Amplatzer Amulet Left Atrial Appendage Occluder
Abbott Medical · System, Appendage Closure, Left Atrial (NGV, Class III) · First FDA decision Aug 14, 2021, newest Apr 22, 2025Stroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
15
Naming "Amplatzer Amulet"
MAUDE reports
2,721
Brand "Amplatzer Amulet", since 2015
PubMed studies
166
Mentioning "Amplatzer Amulet"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Amplatzer Amulet Left Atrial Appendage Occluder
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Amplatzer Amulet Left Atrial Appendage OccluderPMA supplement
P200049-S009 · Decided Apr 22, 2025 · 138 days after receipt · Normal 180 Day Track No User Fee
Device type: System, appendage closure, left atrial (NGV) · Cardiology
- Amplatzer Amulet Left Atrial Appendage OccluderPMA supplement
P200049-S007 · Decided Oct 1, 2024 · 71 days after receipt · Normal 180 Day Track No User Fee
Device type: System, appendage closure, left atrial (NGV) · Cardiology
P200049 · Decided Aug 14, 2021 · 226 days after receipt
Device type: System, appendage closure, left atrial (NGV) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Amplatzer Amulet", any status and sponsor, newest update first.
- Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage ClosurePivotal-lookingRecruiting
Fundación EPICAcademic, hospital or other
NCT07260474 · 200 participants (planned) · Start May 5, 2024 · Primary completion Dec 31, 2026
Device: Patients implanted with Amplatzer Amulet™; Patients implanted with LAmbre™ · For: Coronary Artery Disease
Sites: Fuencarral-El Pardo, Spain
Abbott Medical DevicesPublic (ABT)
NCT06189365 · 50 participants · Start Jan 30, 2024 · Primary completion Dec 5, 2025
Device: Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder · For: Non-Valvular Atrial Fibrillation
Sites: Shenzhen, China; Wuhan, China; Changsha, China · 5 sites in all
- CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke PreventionRecruiting
National Medical Research Center for Therapy and Preventive MedicineGovernment (non-federal)
NCT07575867 · 464 participants (planned) · Start Apr 2026 · Primary completion Apr 2032
Device: Left Atrial Appendage Closure · For: Atrial Fibrillation; Stroke Prevention in Patients With Atrial Fibrillation; Left Atrial Appendage Closure and 4 more
Sites: Moscow, Russia
12 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Amplatzer Amulet", and for the whole product code for context.
This brand
2,721 reports: 288 malfunction, 2,103 injury, 330 death
Whole product code NGV
17,771 reports: 1,912 malfunction, 13,990 injury, 1,862 death
Newest reports for this brand
- Amplatzer AmuletInjury
2135147-2026-07274 · Received Oct 30, 2026 · Event dated Oct 6, 2026
Device type: System, Appendage Closure, Left Atrial (NGV)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pericardial Effusion
- Amplatzer AmuletDeath
2135147-2026-07261 · Received Oct 29, 2026 · Event dated Sep 13, 2026
Device type: System, Appendage Closure, Left Atrial (NGV)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Cardiac Tamponade; Pericardial Effusion
- Amplatzer AmuletInjury
2135147-2026-07265 · Received Oct 29, 2026 · Event dated Dec 31, 2023
Device type: System, Appendage Closure, Left Atrial (NGV)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Tachycardia
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0191-2027 · Started Sep 10, 2026 · Posted by FDA Oct 16, 2026
Reason given: Changes to Instructions for Use (IFU) for the device regarding risk of Pulmonary Artery Injury (PAI).
Cause as FDA categorized it: Labeling design · Device type: System, Appendage Closure, Left Atrial (NGV)
Published research
The most relevant PubMed records for "Amplatzer Amulet"[tiab]. The summary above synthesizes these.
- Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
Lakkireddy D, Thaler D, Ellis CR, et al. · Circulation · 2021Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Left Atrial Appendage Occlusion in Nonagenarians.
Cepas-Guillén PL, Schmidt B, Berti S, et al. · J Invasive Cardiol · 2022Observational Study, Research Support, Non-U.S. Gov't
- Amplatzer Amuletࡊ left atrial appendage occluder: A step-by-step guide to device implantation.
Ellis CR · J Cardiovasc Electrophysiol · 2022Review
- Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: A systematic review and meta-analysis.
Jaiswal V, Ang SP, Shrestha AB, et al. · Medicine (Baltimore) · 2023Meta-Analysis, Systematic Review
- 5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.
Lakkireddy D, Ellis CR, Thaler D, et al. · J Am Coll Cardiol · 2025Randomized Controlled Trial, Multicenter Study
- The Amplatzer Amulet Device: Technical Considerations and Procedural Approach.
Messas N, Ibrahim R · Interv Cardiol Clin · 2018Review
- Computed tomography-based device-sizing in Amplatzer Amulet left atrial appendage occlusion.
Nirmalan JG, Kramer A, Korsholm K, et al. · J Interv Card Electrophysiol · 2024
- Single antiplatelet therapy following Amplatzer left atrial appendage occlusion.
Kramer A, Korsholm K, Nielsen-Kudsk JE · EuroIntervention · 2024Observational Study
- 3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).
Lakkireddy D, Thaler D, Ellis CR, et al. · JACC Cardiovasc Interv · 2023Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Optimal Antithrombotic Regimen in Left Atrial Appendage Occlusion: The Gordian Knot?
Afzal S, Dannenberg L, Kanschik D, et al. · Pharmacology · 2023News
- Left Atrial Appendage Occlusion for Stroke Prevention.
Chanda A, Reilly JP · Prog Cardiovasc Dis · 2017Review
- Comparative Profiles of the WATCHMANࡊ and Amplatzerࡊ Cardiac Plug/Amplatzerࡊ Amuletࡊ Devices for Left Atrial Appendage Closure in Non-valvular Atrial Fibrillation: A Comprehensive Systematic Review and Meta-analysis.
Raja F, Rani K, Kumar S, et al. · J Innov Card Rhythm Manag · 2024Review
Other devices of this type
Also filed under product code NGV.
- Watchman Left Atrial Appendage (Laa) Closure TechnologyBoston Scientific Corp · PMA 2026
- WATCHMAN FLX Left Atrial Appendage (LAA) Closure TechnologyBoston Scientific Corp · PMA 2025
- WATCHMAN FLX Pro Left Atrial Appendage Closure Device with Delivery SystemBoston Scientific Corp · PMA 2025
- Amplatzer Amulet LAA OccluderAbbott Medical · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.